Massimo E. Dottorini
9 Papers
23 Citations
Massimo E. Dottorini is an academic researcher. The author has contributed to research in topics: Vascular dementia & Dementia with Lewy bodies. The author has an hindex of 6, co-authored 9 publications.
Chat about Author
Papers
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease
Matteo Cotta Ramusino,Matteo Cotta Ramusino,Valentina Garibotto,Valentina Garibotto,Ruggero Bacchin,Ruggero Bacchin,Daniele Altomare,Alessandra Dodich,Frédéric Assal,Aline Mendes,Alfredo Costa,Michele Tinazzi,Silvia Morbelli,Matteo Bauckneht,Agnese Picco,Massimo E. Dottorini,Cristina Tranfaglia,Lucia Farotti,Nicola Salvadori,Davide V. Moretti,Giordano Savelli,Anna Tarallo,Flavio Nobili,Maura Parapini,Carlo Cavaliere,Elena Salvatore,Marco Salvatore,Marina Boccardi,Giovanni B. Frisoni +28 more
TL;DR: Amyloid-PET should be prioritized over CSF biomarkers in the diagnostic workup of patients investigated for suspected AD, as it provides greater changes in diagnosis and diagnostic confidence.
27
Radioiodine in the management of benign thyroid disease: clinical guidelines. Report of a Working Party, 2007. Royal College of Physicians (RCP)
Massimo E. Dottorini,Luigi Mansi +1 more
TL;DR: This publication of the Royal College of Physicians of London (RCP) is the result of the work of an inter-disciplinary panel of British experts, representing the several bodies involved in the radioiodine treatment of benign thyroid diseases, permitting a wider evaluation of the main issues involved.
19
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease
Andrea Brugnolo,Fabrizio De Carli,Marco Pagani,S. Morbelli,Cathrine Jonsson,Andrea Chincarini,Giovanni B. Frisoni,Samantha Galluzzi,Robert Perneczky,Alexander Drzezga,Bart N.M. van Berckel,Rik Ossenkoppele,Mira Didic,Eric Guedj,Dario Arnaldi,Federico Massa,Matteo Grazzini,Matteo Pardini,Patrizia Mecocci,Massimo E. Dottorini,Matteo Bauckneht,Gianmario Sambuceti,Flavio Nobili +22 more
TL;DR: The study confirms the good accuracy of [18]F-FDG-PET in discriminating healthy subjects from pAD and highlights that a non-linear, automatic VROI classifier based on SVM performs better than the voxel-based methods.
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.
Federico Massa,Lucia Farotti,Paolo Eusebi,Elisabetta Capello,Massimo E. Dottorini,Cristina Tranfaglia,Matteo Bauckneht,Silvia Morbelli,Flavio Nobili,Lucilla Parnetti +9 more
TL;DR: Real-world data confirm the added values of FDG-PET (or CSF) in a diagnostic pathway where CSF was used as first biomarkers in suspected AD, and should be replicated in larger studies with prospective enrolment according to a Phase III design.
11
Ic‐p‐006: the incremental value of amyloid pet versus csf biomarkers for the diagnosis of alzheimer's disease (india–fbb study)
Matteo Cotta Ramusino,Daniele Altomare,Frédéric Assal,Aline Mendes,Alfredo Costa,Silvia Morbelli,Matteo Bauckneht,Agnese Picco,Massimo E. Dottorini,Lucia Farotti,Davide V. Moretti,Giordano Savelli,Anna Tarallo,Lucilla Parnetti,Flavio Nobili,Maura Parapini,Elena Salvatore,Marco Salvatore,Marina Boccardi,Giovanni B. Frisoni +19 more
TL;DR: This research presents a novel probabilistic approach to Alzheimer's disease that combines cell reprograming, using a “spatially aggregating” approach, which combines “cell-based” and “dynamic” approaches.
3